UY37949A - Proceso para preparar benzotiofen-2il boronato - Google Patents

Proceso para preparar benzotiofen-2il boronato

Info

Publication number
UY37949A
UY37949A UY0001037949A UY37949A UY37949A UY 37949 A UY37949 A UY 37949A UY 0001037949 A UY0001037949 A UY 0001037949A UY 37949 A UY37949 A UY 37949A UY 37949 A UY37949 A UY 37949A
Authority
UY
Uruguay
Prior art keywords
boronate
benzotiofen
prepare
medicaments
production
Prior art date
Application number
UY0001037949A
Other languages
English (en)
Inventor
Jörg Gries Dr
Johannes Platzek Dr
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of UY37949A publication Critical patent/UY37949A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un proceso para preparar el benzotiofen-2-il boronato de fórmula (VI) que sirve como intermediario para la producción de medicamentos y para la producción de medicamentos para el tratamiento y/o la profilaxis de trastornos proliferativos, como, por ejemplo, cáncer y enfermedades tumorales.
UY0001037949A 2017-10-25 2018-10-25 Proceso para preparar benzotiofen-2il boronato UY37949A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17198336 2017-10-25

Publications (1)

Publication Number Publication Date
UY37949A true UY37949A (es) 2019-05-31

Family

ID=60293714

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001037949A UY37949A (es) 2017-10-25 2018-10-25 Proceso para preparar benzotiofen-2il boronato

Country Status (20)

Country Link
US (2) US11274110B2 (es)
EP (1) EP3700894A1 (es)
JP (1) JP2021500392A (es)
KR (1) KR20200074128A (es)
CN (1) CN111225907B (es)
AR (1) AR113793A1 (es)
AU (1) AU2018354780A1 (es)
BR (1) BR112020008063A2 (es)
CA (1) CA3084755A1 (es)
CL (1) CL2020001093A1 (es)
CO (1) CO2020004984A2 (es)
IL (1) IL273952A (es)
JO (1) JOP20200090A1 (es)
MX (1) MX2020004285A (es)
PE (1) PE20211268A1 (es)
SG (1) SG11202002199RA (es)
TW (1) TWI784074B (es)
UA (1) UA126592C2 (es)
UY (1) UY37949A (es)
WO (1) WO2019081346A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10947552B1 (en) 2020-09-30 2021-03-16 Alpine Roads, Inc. Recombinant fusion proteins for producing milk proteins in plants
US10894812B1 (en) 2020-09-30 2021-01-19 Alpine Roads, Inc. Recombinant milk proteins
CA3191387A1 (en) 2020-09-30 2022-04-07 Nobell Foods, Inc. Recombinant milk proteins and food compositions comprising the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20030355A1 (it) * 2003-07-18 2005-01-19 Sigma Tau Ind Farmaceuti Composti ad attivita' citotossica derivati della combretastatina.
US20090047246A1 (en) * 2007-02-12 2009-02-19 Intermune, Inc. Novel inhibitors of hepatitis c virus replication
US20110201815A1 (en) * 2008-10-15 2011-08-18 Kissei Pharmaceutical Co., Ltd. Fused heterocyclic derivative and use thereof for medical purposes
WO2013087647A1 (en) * 2011-12-15 2013-06-20 Bayer Intellectual Property Gmbh Substituted benzothienyl - pyrrolotriazines and uses thereof in the treatment cancer
UY34484A (es) 2011-12-15 2013-07-31 Bayer Ip Gmbh Benzotienilo-pirrolotriazinas disustituidas y sus usos

Also Published As

Publication number Publication date
EP3700894A1 (en) 2020-09-02
JOP20200090A1 (ar) 2020-05-03
TW201925211A (zh) 2019-07-01
MX2020004285A (es) 2020-07-29
WO2019081346A1 (en) 2019-05-02
TWI784074B (zh) 2022-11-21
CA3084755A1 (en) 2019-05-02
SG11202002199RA (en) 2020-04-29
US11274110B2 (en) 2022-03-15
CL2020001093A1 (es) 2020-10-23
PE20211268A1 (es) 2021-07-19
RU2020115600A3 (es) 2022-03-29
CN111225907A (zh) 2020-06-02
CO2020004984A2 (es) 2020-05-05
CN111225907B (zh) 2023-05-26
RU2020115600A (ru) 2021-11-25
US20220356194A1 (en) 2022-11-10
UA126592C2 (uk) 2022-11-02
US20200339606A1 (en) 2020-10-29
BR112020008063A2 (pt) 2020-11-03
KR20200074128A (ko) 2020-06-24
IL273952A (en) 2020-05-31
AR113793A1 (es) 2020-06-10
JP2021500392A (ja) 2021-01-07
AU2018354780A1 (en) 2020-04-09

Similar Documents

Publication Publication Date Title
NI201600144A (es) Derivados de quinoxalina utiles como moduladores del fgfr cinasa
ECSP24026455A (es) Compuestos de pirrolotriazina como inhibidores de tam
CO2021006672A2 (es) Moduladores de nlrp3
CL2019002304A1 (es) Compuestos para el tratamiento del cáncer.
CL2019001369A1 (es) Composición farmacéutica para prevenir o tratar el cáncer de mama, incluido el polimorfo cristalino del hexoxido tetraarsenico y el método para producirlo.
UY37124A (es) Nuevos compuestos de 6,7-dihidro-5h-benzo[7]anuleno sustituidos, procesos para su preparación y usos terapéuticos de los mismos
ECSP20033467A (es) Compuestos macrocíclicos para tratar enfermedades
CL2018003123A1 (es) Terapia de combinación para el tratamiento del cáncer
SG10201806849WA (en) Cyclopropylamines as lsd1 inhibitors
BR112017009497A2 (pt) polinucleotídeos de aadc para o tratamento da doença de parkinson
MX2020001757A (es) Compuestos, sales de los mismos y metodos para el tratamiento de enfermedades.
CL2020000085A1 (es) Moduladores de nlrp3.
PH12019502363A1 (en) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds
CO2020004984A2 (es) Proceso para preparar el benzotiofen-2-il boronato
BR112017000714A2 (pt) indols funcionalizados e substituídos como agentes anti-câncer
MX2019012938A (es) Uso del inhibidor mejorador de homologo zeste 2 (ezh2) combinado con el inhibidor tirosina cinasa de bruton (btk) en la preparacion de farmacos para tratar tumores.
DOP2018000238A (es) Inhibidores del potenciador del homólogo zeste 2
PH12019502693A1 (en) Heteroaromatic compounds as vanin inhibitors
CR20160558A (es) Compuesto de 1, 3, 4 - tiadiazol y uso de los mismos para el tratamiento del cáncer
UY36758A (es) Inhibidores del potenciador del homólogo zeste 2
CO2018003756A2 (es) Derivados de éter cíclico de pirazolo[1,5-a]pirimidin-3-carboxiamida
MX2018007517A (es) Compuestos triciclicos y composiciones como inhibidores de quinasa.
BR112017016333A2 (pt) compostos anticâncer
IN2013MU03118A (es)
EA202090283A1 (ru) Модуляторы nlrp3

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20231114